Ironwood Pharmaceuticals (IRWD) Gross Profit (2017 - 2020)
Ironwood Pharmaceuticals' Gross Profit history spans 7 years, with the latest figure at $115.8 million for Q4 2020.
- On a quarterly basis, Gross Profit changed 0.43% to $115.8 million in Q4 2020 year-over-year; TTM through Dec 2020 was $386.4 million, a 26.36% increase, with the full-year FY2020 number at $386.4 million, down 4.49% from a year prior.
- Gross Profit hit $115.8 million in Q4 2020 for Ironwood Pharmaceuticals, up from $103.5 million in the prior quarter.
- Over the last five years, Gross Profit for IRWD hit a ceiling of $115.8 million in Q4 2020 and a floor of -$21.3 million in Q4 2018.
- Historically, Gross Profit has averaged $69.9 million across 4 years, with a median of $77.4 million in 2018.
- Biggest five-year swings in Gross Profit: tumbled 124.95% in 2018 and later skyrocketed 642.2% in 2019.
- Tracing IRWD's Gross Profit over 4 years: stood at $85.2 million in 2017, then tumbled by 124.95% to -$21.3 million in 2018, then skyrocketed by 642.2% to $115.3 million in 2019, then rose by 0.43% to $115.8 million in 2020.
- Business Quant data shows Gross Profit for IRWD at $115.8 million in Q4 2020, $103.5 million in Q3 2020, and $89.4 million in Q2 2020.